Royal Bank of Canada’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
180
﹤0.01% 7497
2025
Q4
$0 Buy
+180
New +$375 ﹤0.01% 7471
2025
Q3
Sell
-1,167
Closed -$3K 7379
2025
Q2
$3K Hold
1,167
﹤0.01% 6749
2025
Q1
$3K Hold
1,167
﹤0.01% 6510
2024
Q4
$3K Hold
1,167
﹤0.01% 6656
2024
Q3
$3K Hold
1,167
﹤0.01% 6608
2024
Q2
$3K Hold
1,167
﹤0.01% 6664
2024
Q1
$3K Hold
1,167
﹤0.01% 6606
2023
Q4
$3K Hold
1,167
﹤0.01% 6739
2023
Q3
$4K Hold
1,167
﹤0.01% 6672
2023
Q2
$3K Hold
1,167
﹤0.01% 6796
2023
Q1
$1K Hold
1,167
﹤0.01% 6912
2022
Q4
$1K Hold
1,167
﹤0.01% 7057
2022
Q3
$2K Hold
1,167
﹤0.01% 7044
2022
Q2
$2K Hold
1,167
﹤0.01% 6977
2022
Q1
$4K Hold
1,167
﹤0.01% 7329
2021
Q4
$4K Hold
1,167
﹤0.01% 7279
2021
Q3
$5K Hold
1,167
﹤0.01% 7135
2021
Q2
$6K Hold
1,167
﹤0.01% 7029
2021
Q1
$12K Sell
1,167
-666
-36% -$7.93K ﹤0.01% 6719
2020
Q4
$9K Hold
1,833
﹤0.01% 6431
2020
Q3
$9K Buy
1,833
+666
+57% +$4.22K ﹤0.01% 5957
2020
Q2
$8K Hold
1,167
﹤0.01% 5915
2020
Q1
$11K Hold
1,167
﹤0.01% 5797
2019
Q4
$19K Buy
+1,167
New +$18.5K ﹤0.01% 5873

Other funds holding NSPR

Royal Bank of Canada's NSPR Position: Q1 2026 in Review

Royal Bank of Canada held its InspireMD (NSPR) position steady in Q1 2026 at 180 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7497.

Royal Bank of Canada first reported a position in NSPR in Q4 2019 and has held it in 25 quarters since. The position peaked at $19K in Q4 2019. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Royal Bank of Canada held 180 shares of InspireMD worth $0 as of Q1 2026.
  • Royal Bank of Canada left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7497 holding.
  • Royal Bank of Canada first reported a position in InspireMD in Q4 2019 and has held it in 25 quarters since.
  • Royal Bank of Canada's InspireMD position peaked at $19K in Q4 2019.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.